In Crohn's Disease, Anti-TNF-<svg style="vertical-align:-0.15048pt;width:10.5px;" id="M1" height="7.5124998" version="1.1" viewBox="0 0 10.5 7.5124998" width="10.5"  xmlns="http://www.w3.org/2000/svg">
	<g transform="matrix(1.25,0,0,-1.25,0,7.5125)">
		<g transform="translate(72,-65.99)">
			<text transform="matrix(1,0,0,-1,-71.95,66.19)">
				<tspan style="font-size: 12.50px; " x="0" y="0">𝜶</tspan>
			</text>

		</g>
	</g>
</svg> Treatment Changes the Balance between Mucosal IL-17, FOXP3, and CD4 Cells

<table>Ratio of IL-17<sup>+</sup> cells to CD4<sup>+ </sup>cells in ileal biopsy samples in active CD before 0 and 3 months after beginning of anti-TNF-<i>α</i> treatment and control subjects. </table>

International Scholarly Research Notices

fig3

Figure 3

Figure 3: In Crohn's Disease, Anti-TNF-<svg style="vertical-align:-0.15048pt;width:10.5px;" id="M1" height="7.5124998" version="1.1" viewBox="0 0 10.5 7.5124998" width="10.5"  xmlns="http://www.w3.org/2000/svg">
	<g transform="matrix(1.25,0,0,-1.25,0,7.5125)">
		<g transform="translate(72,-65.99)">
			<text transform="matrix(1,0,0,-1,-71.95,66.19)">
				<tspan style="font-size: 12.50px; " x="0" y="0">𝜶</tspan>
			</text>

		</g>
	</g>
</svg> Treatment Changes the Balance between Mucosal IL-17, FOXP3, and CD4 Cells 

International Scholarly Research Notices

In Crohn's Disease, Anti-TNF- 𝜶 Treatment Changes the Balance between Mucosal IL-17, FOXP3, and CD4 Cells

Figure 3

In Crohn's Disease, Anti-TNF- Treatment Changes the Balance between Mucosal IL-17, FOXP3, and CD4 Cells